Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Erica Mayer

28PUBLICATIONS
214CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targetsHealth informatics and information systemsChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

Sort by Publication Date:
|Oct 14, 2025
Oncology's ongoing struggle with evaluating quality of life limiting, treatment-related toxicity.

Seamus O'Reilly, Siobhan Gaynor, Erica L Mayer

|Aug 25, 2025
Circulating Tumor Cell Dynamics after CDK4/6 Inhibitor for Hormone Receptor-Positive Metastatic Breast Cancer: A Biomarker Analysis from the PACE Phase II Study.

Lorenzo Gerratana, Carolina Reduzzi, Yue Ren

|Jun 02, 2025
First-Line Camizestrant for Emerging <i>ESR1</i>-Mutated Advanced Breast Cancer.

François-Clément Bidard, Erica L Mayer, Yeon Hee Park

|Feb 06, 2025
Patient preferences for CDK4/6 inhibitor treatments in HR+/HER2- early breast cancer: a discrete choice survey study.

Erica L Mayer, Mary Lou Smith, Annie Guérin

|Oct 09, 2024
Further Optimizing Care of Patients With Operable Hormone Receptor-Sensitive Breast Cancer.

Alexandra Thomas, Erica L Mayer, Angela DeMichele

|Sep 03, 2024
A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast Cancer.

Antonio Giordano, Priya U Kumthekar, Qingchun Jin

Pageof 5

Frequent Collaborators

8 joint publications

Angela M DeMichele

7 joint publications

Sara Tolaney

7 joint publications

Antonio C Wolff

6 joint publications

Eric P Winer

5 joint publications

Ingrid A Mayer

4 joint publications

Massimo Cristofanilli

3 joint publications

Hiroji Iwata

3 joint publications

Michael Gnant

3 joint publications

Amylou Dueck

3 joint publications

Christian Fesl

Frequent Collaborators

8 joint publications

Angela M DeMichele

7 joint publications

Sara Tolaney

7 joint publications

Antonio C Wolff

6 joint publications

Eric P Winer

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.6K
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on : Feb 28, 2014

16.0K
The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma
12:44

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma

Published on : Jul 17, 2013

25.7K
See more related videos

Top Related Videos

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
10:49

Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia

Published on : Sep 18, 2013

18.6K
Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications
14:14

Adaptation of Semiautomated Circulating Tumor Cell (CTC) Assays for Clinical and Preclinical Research Applications

Published on : Feb 28, 2014

16.0K
The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma
12:44

The <em>In ovo</em> CAM-assay as a Xenograft Model for Sarcoma

Published on : Jul 17, 2013

25.7K
See more related videos